COMMUNIQUÉS West-GlobeNewswire

Emerald Health Therapeutics Applauds the Government of Canada for the Release of Final Ingestible Regulations
14/06/2019
Final regulatory framework positions Emerald for further growth VANCOUVER, British Columbia, June 14, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) is pleased that [...]
UPDATE - Mesoblast to Host Virtual Symposium With Key Opinion Leader Highlighting Acute Graft Versus Host Disease
14/06/2019
NEW YORK and MELBOURNE, Australia, June 14, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ: MESO; ASX: MSB), global leader in cellular medicines for inflammatory diseases, today announced that it will host a virtual [...]
Canada House Wellness Group Inc. Update on Canada House Clinic Expansion
14/06/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 14, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“ Canada House ” or the “ Company ”), a fully [...]
Cytovance® Biologics Inc., Completes Its Second FDA Pre-Approval Inspection (PAI) of Oklahoma City, OK Facilities
14/06/2019
OKLAHOMA CITY, June 14, 2019 (GLOBE NEWSWIRE) -- Cytovance® Biologics announced that it has received a notification letter and an Establishment Inspection Reports (EIRs) from the U.S. Food and Drug Administration (FDA) [...]
LifePod and iHome Announce Strategic Collaboration to Launch Groundbreaking Proactive-Voice Virtual Caregiver Service
14/06/2019
BOSTON, June 14, 2019 (GLOBE NEWSWIRE) -- During CE Week in New York, LifePod Solutions Inc. announced a strategic collaboration with SDI Technologies Inc., and their iHome division, to bring to market a first-of-its- [...]
Mesoblast to Host Virtual Symposium With Key Opinion Leader Highlighting Acute Graft Versus Host Disease
14/06/2019
NEW YORK and MELBOURNE, Australia, June 14, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ: MESO; ASX: MSB), global leader in cellular medicines for inflammatory diseases, today announced that it will host a virtual [...]
Sienna Announces June Dividend
14/06/2019
MARKHAM, Ontario, June 14, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.0765 per common share of the Company (each, a “ Common Share ”) [...]
Nemaura Medical Interview to Air on Bloomberg International on the RedChip Money Report
14/06/2019
Loughborough, England, June 14, 2019 (GLOBE NEWSWIRE) -- – Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible [...]
Avadim Health Announces the Launch of its Second Consumer Clinical Innovation, Theraworx® Relief for Arthritic Joint Discomfort and Inflammation
14/06/2019
Theraworx® Relief, for Arthritic Joint Discomfort and Inflammation, Launching in 22,000 Pharmacy Locations Nationwide ASHEVILLE, N.C., June 14, 2019 (GLOBE NEWSWIRE) -- Avadim Health, Inc. (“Avadim”), the Bionome [...]
SELLAS Life Sciences Announces Pricing of $15 Million Public Offering
14/06/2019
NEW YORK, June 14, 2019 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a clinical stage biopharmaceutical company focused on the development of novel cancer [...]
Aura Signs Master Grower for Israel
14/06/2019
TORONTO, June 14, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the “ Company ” or “ Aura ”) ( CSE:BUZZ ) is pleased to announce the signing of master grower, Adrian Richelmi, to build and operate HolyCanna’s 60,000 square [...]
Krystal Submits Investigational New Drug (IND) Application for KB105, Topical Gene Therapy Candidate for Transglutaminase-1 Deficient Autosomal Recessive Congenital Ichthyosis
14/06/2019
KB105 is a new gene therapy candidate engineered with a Transglutaminase-1 (TGM1) gene construct to treat TGM1 deficient autosomal recessive congenital ichthyosis KB105 is the second pipeline product based on the STAR-D [...]
ORYZON Presents Preliminary Dose Finding Results of Phase II Trial With Iadademstat in AML
14/06/2019
Results presented at 24 th Congress of EHA in Amsterdam Combination of iadademstat and azacitidine shows good safety profile in elderly AML patients Recommended dose for Phase II established with only six patients Quick [...]
Bellwyck Pharma Services on Growth Path
14/06/2019
Expands Cold Storage Space in U.S., Adds Packaging Services in EU BURLINGTON, Ontario, June 14, 2019 (GLOBE NEWSWIRE) -- Bellwyck Pharma Services, a leader in primary and secondary packaging and labeling for the [...]
New Data Released by Theratechnologies Demonstrate Positive Impact of Tesamorelin in Patients With Liver Fibrosis
14/06/2019
NASH Development Strategy for tesamorelin to be Unveiled on June 17, 2019 MONTREAL, June 14, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce additional data from the [...]
De nouvelles données divulguées par Theratechnologies démontrent l’impact positif de la tésamoréline sur les patients présentant une fibrose du foie
14/06/2019
La stratégie de développement de la tésamoréline pour le NASH sera dévoilée le 17 juin 2019 MONTRÉAL, 14 juin 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer de [...]
G1 Therapeutics to Present Patient-Reported Outcomes (PRO) Data on Trilaciclib At Multinational Association of Supportive Care in Cancer (MASCC) And International Society of Oral Oncology (ISCOO) 2019 Annual Meeting
14/06/2019
RESEARCH TRIANGLE PARK, N.C., June 14, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that an analysis of patient-reported outcomes (PRO) data from [...]
Immunophotonics and Clinical Laserthermia Systems Announce Immuno-Oncology Research Collaboration and Clinical Trials for Cancer Patients with Solid Tumors
14/06/2019
Collaboration will Combine Immunophotonics’ Proprietary Drug, IP-001, and CLS’s TRANBERG Laser Thermal Therapy System and imILT Method ST. LOUIS and IRVINE, Calif., June 14, 2019 (GLOBE NEWSWIRE) -- Immunophotonics, Inc [...]
Immunophotonics and Clinical Laserthermia Systems Announce Immuno-Oncology Research Collaboration and Clinical Trials for Cancer Patients with Solid Tumors
14/06/2019
Collaboration will Combine Immunophotonics’ Proprietary Drug, IP-001, and CLS’s TRANBERG Laser Thermal Therapy System and imILT Method ST. LOUIS and LUND, Sweden, June 14, 2019 (GLOBE NEWSWIRE) -- Immunophotonics, Inc. [...]

Pages